로딩 중…
지수 로딩 중…
Esperion Therapeutics, Inc.
ESPR· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$3.15-0.63%
2026-06-18
Price Chart
Esperion Therapeutics, Inc.+186.36%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $811M |
| Revenue | $418M |
| Net Income | $-7M |
| Total Assets | $463M |
| Net Assets | $-308M |
| Value | |
| P/S | 1.94x |
| EV/EBITDA | 11.76x |
| FCF Yield | -2.24% |
| Profitability | |
| ROA | -1.60% |
| Op. Margin | 18.12% |
| Revenue Growth | 23.25% |
| Financial Health | |
| Total Debt | $253M |
| FCF | $-18M |
| Cash | $156M |
| Current Ratio | 1.53x |
| Net Debt/EBITDA | 1.25x |
| Performance | |
| 1Y Return | 186.36% |
| 1M Return | 0.64% |
| From 52W High | -24.64% |
| 1Y MDD | -53.19% |
| Trading | |
| Volume | 17,013,411 shares |
| Trading Value | $54M |
| Per Share | |
| EPS | $-0.10 |